Functional Fermented Milk with Probiotic Lacticaseibacillus rhamnosus CRL75 Alleviates Allergic Enteritis by Inducing Th1 Immune Response
Probiotics and Antimicrobial Proteins · 07.11.2026
DOI: 10.1007/s12602-026-11292-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 07.11.2026. Verfasst von Jonathan Emiliano Laiño und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Referencia para Lactobacilos (CERELA-CONICET), Chacabuco 145, San Miguel de Tucumán, Tucumán, T4000ILC, Argentina. jlaino@cerela.org.ar. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Consejo Nacional de Investigaciones Científicas y Técnicas.
Abstract (Originalsprache)
Food allergy is an adverse health condition with global distribution and prevalence, with no cure. The main approach for prevention is strict avoidance of the allergen in the food. New alternatives to prevent or reduce symptoms are necessary to improve quality of life, such as probiotics. This study aimed to evaluate the ability of Lacticaseibacillus (Lact.) rhamnosus CRL75 to prevent allergic enteritis development when administered in drinking water or in fermented milk in an ovalbumin (OVA)-induced intestinal allergy mouse model. Preventive and simultaneous administration of CRL75 in drinking water and in fermented milk significantly reduced OVA-specific immunoglobulin (Ig) E but increased OVA-specific IgG, IgG1, and IgG2a. In addition, CRL75 induced release of interferon gamma (IFN-γ) and interleukin (IL) 10, decreasing IL-4 and IL-6 in serum, and reduced eosinophil recruitment to the intestine. Splenocytes from CRL75-treated mice showed significantly reduced secretion of IL-4 and IL-6 and increased IFN-γ, IL-10, and tumor necrosis factor alpha (TNF-α). Preventive administration of CRL75 in drinking water and fermented milk reduced Th2 immune response in OVA-induced intestinal allergy, leading to a Th1 response. Lact. rhamnosus CRL75 represents a viable, useful, and affordable alternative for the design of novel functional foods aimed at contributing to the prevention of allergic enteritis. Moreover, it is the first report to compare and demonstrate that in both fermented milk or drinking water, Lact. rhamnosus CRL75 prevents and reduces allergic reactions, shifting the Th1/Th2 balance towards the Th1 response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Referencia para Lactobacilos (CERELA-CONICET), Chacabuco 145, San Miguel de Tucumán, Tucumán, T4000ILC, Argentina. jlaino@cerela.org.ar.
- Cátedra de Bioquímica Clínica I, Instituto de Bioquímica Aplicada, Facultad de Bioquímica, Química y Farmacia, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Tucumán, San M…
- Centro de Referencia para Lactobacilos (CERELA-CONICET), Chacabuco 145, San Miguel de Tucumán, Tucumán, T4000ILC, Argentina.
Förderung
- Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
- Consejo Nacional de Investigaciones Científicas y Técnicas
Zitieren
APA
Laiño, J. E., Zelaya, M. H., & Taranto, M. P. (2026). Functional Fermented Milk with Probiotic Lacticaseibacillus rhamnosus CRL75 Alleviates Allergic Enteritis by Inducing Th1 Immune Response. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-026-11292-4
Vancouver
Laiño JE, Zelaya MH, Taranto MP. Functional Fermented Milk with Probiotic Lacticaseibacillus rhamnosus CRL75 Alleviates Allergic Enteritis by Inducing Th1 Immune Response. Probiotics and Antimicrobial Proteins. 2026. doi:10.1007/s12602-026-11292-4
BibTeX
@article{Laio2026,
author = {Laiño, Jonathan Emiliano and Zelaya, María Hortensia and Taranto, María Pía},
title = {Functional Fermented Milk with Probiotic Lacticaseibacillus rhamnosus CRL75 Alleviates Allergic Enteritis by Inducing Th1 Immune Response},
journal = {Probiotics and Antimicrobial Proteins},
year = {2026},
doi = {10.1007/s12602-026-11292-4}
}
EUVIMED